Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (28) 28
index medicus (28) 28
obesity (16) 16
endocrinology & metabolism (15) 15
male (15) 15
digestive, oral, and skin physiology (14) 14
humans (14) 14
mice (13) 13
food-intake (12) 12
rats (11) 11
ghrelin - metabolism (10) 10
hormones, hormone substitutes, and hormone antagonists (10) 10
abridged index medicus (9) 9
insulin (8) 8
metabolism (8) 8
mice, knockout (8) 8
body weight (7) 7
body-weight (7) 7
eating - drug effects (7) 7
endocrine system (7) 7
endocrinology (7) 7
ghrelin (7) 7
glucose (7) 7
hormone secretagogue receptor (7) 7
physiological aspects (7) 7
diabetes (6) 6
energy-balance (6) 6
ghrelin - pharmacology (6) 6
obesity - metabolism (6) 6
research (6) 6
acylation (5) 5
acyltransferases - metabolism (5) 5
analysis (5) 5
arcuate nucleus (5) 5
article (5) 5
care and treatment (5) 5
eating - physiology (5) 5
energy metabolism - drug effects (5) 5
female (5) 5
glucagon-like peptide-1 receptor (5) 5
glucose - metabolism (5) 5
glucose tolerance test (5) 5
mice, inbred c57bl (5) 5
rats, long-evans (5) 5
receptors, ghrelin - metabolism (5) 5
receptors, glucagon - agonists (5) 5
receptors, glucagon - metabolism (5) 5
unacylated ghrelin (5) 5
acyltransferases - genetics (4) 4
blood glucose - metabolism (4) 4
body composition - drug effects (4) 4
body weight - drug effects (4) 4
eating (4) 4
energy metabolism - physiology (4) 4
glucagon (4) 4
hormones (4) 4
insulin - metabolism (4) 4
insulin-resistance (4) 4
peptide (4) 4
receptors, glucagon - genetics (4) 4
rodents (4) 4
signal transduction - drug effects (4) 4
adipose tissue, brown - metabolism (3) 3
adiposity (3) 3
animal models (3) 3
beta-cells (3) 3
biology (3) 3
body composition (3) 3
brown adipose-tissue (3) 3
cell biology (3) 3
circulating ghrelin (3) 3
des-acyl ghrelin (3) 3
diet, high-fat (3) 3
fibroblast growth factors (3) 3
genetic aspects (3) 3
ghrelin - administration & dosage (3) 3
ghrelin - blood (3) 3
glp-1 (3) 3
glucagon - metabolism (3) 3
glucagon-like peptide 1 - metabolism (3) 3
glucagon-like peptide-1 (3) 3
glucose metabolism (3) 3
growth-hormone (3) 3
health aspects (3) 3
homeostasis (3) 3
infusions, intraventricular (3) 3
insulin resistance (3) 3
insulin-secretion (3) 3
liraglutide (3) 3
models, biological (3) 3
multidisciplinary sciences (3) 3
neuropeptide-y (3) 3
neurosciences (3) 3
obesity - drug therapy (3) 3
phenotype (3) 3
rat-brain (3) 3
receptors, ghrelin - genetics (3) 3
research article (3) 3
signal transduction (3) 3
stimulated insulin-secretion (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Regulation of glucose metabolism by the ghrelin system: Multiple players and multiple actions
by Heppner, Kristy M and Tong, Jenny
European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - R32
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery
by Bozadjieva, Nadejda and Heppner, Kristy M and Seeley, Randy J and Seeley, Randy J
Diabetes, ISSN 0012-1797, 09/2018, Volume 67, Issue 9, pp. 1720 - 1728
Bariatric surgery procedures, such as Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG), are the most effective interventions available for... 
Obesity, Morbid - surgery | Humans | Metabolic Diseases - drug therapy | Fibroblast Growth Factors - metabolism | Obesity, Morbid - physiopathology | Liver - drug effects | Enterohepatic Circulation - drug effects | Fibroblast Growth Factors - agonists | Bariatric Surgery - adverse effects | Obesity, Morbid - metabolism | Obesity, Morbid - therapy | Hypoglycemic Agents - therapeutic use | Molecular Targeted Therapy - adverse effects | Liver - metabolism | Gastrointestinal Microbiome | Bile Acids and Salts - metabolism | Receptors, Cytoplasmic and Nuclear - agonists | Combined Modality Therapy - adverse effects | Organ Specificity | Animals | Metabolic Diseases - metabolism | Signal Transduction - drug effects | Metabolic Diseases - etiology | Models, Biological | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Fibroblast Growth Factors - antagonists & inhibitors | Metabolic Diseases - microbiology | Receptors, Cytoplasmic and Nuclear - metabolism | Obesity | Care and treatment | Usage | Bile acids | Surgery | Metabolic diseases | Fibroblast growth factors | Health aspects | s in Diabetes | 0706
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text GLP-1 based therapeutics: simultaneously combating T2DM and obesity
by Heppner, Kristy M and Perez-Tilve, Diego
Frontiers in neuroscience, ISSN 1662-4548, 2015, Volume 9, p. 92
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
by Heppner, Kristy M and Tong, Jenny
European journal of endocrinology / European Federation of Endocrine Societies, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - 32
Ghrelin is a 28-amino acid peptide secreted mainly from the X/A-like cells of the stomach. Ghrelin is found in circulation in both des-acyl (dAG) and acyl... 
VERTICAL SLEEVE GASTRECTOMY | STIMULATED INSULIN-SECRETION | UNACYLATED GHRELIN | NONACYLATED GHRELIN | Y GASTRIC BYPASS | BETA-CELLS | ENDOCRINOLOGY & METABOLISM | HORMONE SECRETAGOGUE RECEPTOR | O-ACYLTRANSFERASE GOAT | PANCREATIC-ISLET CELLS | DES-ACYL GHRELIN | Ghrelin - metabolism | Animals | Humans | Glucose - metabolism | Receptors, Ghrelin - metabolism | Endocrinology | Acylation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fibroblast growth factor 21 mediates specific glucagon actions
by Habegger, Kirk M and Stemmer, Kerstin and Cheng, Christine and Müller, Timo D and Heppner, Kristy M and Ottaway, Nickki and Holland, Jenna and Hembree, Jazzminn L and Smiley, David and Gelfanov, Vasily and Krishna, Radha and Arafat, Ayman M and Konkar, Anish and Belli, Sara and Kapps, Martin and Woods, Stephen C and Hofmann, Susanna M and D'Alessio, David and Pfluger, Paul T and Perez-Tilve, Diego and Seeley, Randy J and Konishi, Morichika and Itoh, Nobuyujki and Kharitonenkov, Alexei and Spranger, Joachim and DiMarchi, Richard D and Tschöp, Matthias H
Diabetes, ISSN 0012-1797, 05/2013, Volume 62, Issue 5, pp. 1453 - 1463
Glucagon, an essential regulator of glucose homeostasis, also modulates lipid metabolism and promotes weight loss, as reflected by the wasting observed in... 
PPAR-ALPHA | BODY-WEIGHT | METABOLISM | FIBROBLAST-GROWTH-FACTOR-21 | PHARMACOLOGY | INCREASES ENERGY-EXPENDITURE | ENDOCRINOLOGY & METABOLISM | DEGRADATION | MICE | INSULIN SENSITIVITY | FGF21 | Obesity - drug therapy | Humans | Peptides - pharmacokinetics | Fibroblast Growth Factors - genetics | Male | Fibroblast Growth Factors - secretion | Obesity - blood | Anti-Obesity Agents - therapeutic use | Glucagon - agonists | Fibroblast Growth Factors - metabolism | Anti-Obesity Agents - pharmacokinetics | Peptides - chemical synthesis | Hepatocytes - secretion | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Hypoglycemic Agents - pharmacokinetics | Peptides - physiology | Rats | Hypoglycemic Agents - pharmacology | Mice, Knockout | Cross-Over Studies | Anti-Obesity Agents - chemical synthesis | Mice | Anti-Obesity Agents - pharmacology | Hepatocytes - pathology | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Molecular Targeted Therapy | Mice, Mutant Strains | HEK293 Cells | Adult | Female | Hepatocytes - drug effects | Recombinant Proteins - metabolism | Double-Blind Method | Cells, Cultured | Insulin Resistance | Receptors, Glucagon - metabolism | Recombinant Proteins - agonists | Glucagon - pharmacology | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Fibroblast Growth Factors - blood | Hypoglycemic Agents - chemical synthesis | Glucagon - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - therapeutic use | Physiological aspects | Fibroblast growth factors | Research | Glucagon | Analysis | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text GLP-1 based therapeutics: Simultaneously combating T2DM and obesity
by Heppner, Kristy M and Perez-Tilve, Diego
Frontiers in Neuroscience, ISSN 1662-4548, 03/2015, Volume 9
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts... 
Obesity | CNS | GLP-1 | Diabetes | Insulin | insulin | FOOD-INTAKE | RECEPTOR AGONISTS | NEUROSCIENCES | ENERGY-BALANCE | BODY-WEIGHT | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | GLUCAGON-LIKE PEPTIDE-1 | CENTRAL-NERVOUS-SYSTEM | ADIPOSE-TISSUE THERMOGENESIS | diabetes | TYPE-2 DIABETES-MELLITUS | obesity | PRIMATE MACACA-MULATTA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The metabolic actions of glucagon revisited
by Heppner, Kristy M and Geary, Nori and Bartness, Timothy J and Habegger, Kirk M and DiMarchi, Richard and Tschöp, Matthias H
Nature Reviews Endocrinology, ISSN 1759-5029, 12/2010, Volume 6, Issue 12, pp. 689 - 697
The initial identification of glucagon as a counter-regulatory hormone to insulin revealed this hormone to be of largely singular physiological and... 
INDUCED HEPATIC STEATOSIS | MOUSE PANCREATIC ALPHA | ACTIVATED PROTEIN-KINASE | SPONTANEOUS MEAL SIZE | FATTY-ACID OXIDATION | RECEPTOR KNOCKOUT MICE | ENDOCRINOLOGY & METABOLISM | BROWN ADIPOSE-TISSUE | CARNITINE PALMITOYLTRANSFERASE-I | LACTATING DAIRY-COWS | DIPEPTIDYL PEPTIDASE-IV | Humans | Glucagon - physiology | Metabolism - physiology | Glucagon - pharmacology | Obesity - metabolism | Adipose Tissue - metabolism | Animals | Models, Biological | Metabolism - drug effects | Lipid Metabolism - drug effects | Energy Metabolism - physiology | Adipose Tissue - drug effects | Energy Metabolism - drug effects | Lipid Metabolism - physiology | Metabolism - genetics | Physiological aspects | Obesity | Care and treatment | Research | Metabolic syndrome X | Glucagon
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling
by Lockie, Sarah H and Heppner, Kristy M and Chaudhary, Nilika and Chabenne, Joseph R and Morgan, Donald A and Veyrat-Durebex, Christelle and Ananthakrishnan, Gayathri and Rohner-Jeanrenaud, Françoise and Drucker, Daniel J and DiMarchi, Richard and Rahmouni, Kamal and Oldfield, Brian J and Tschöp, Matthias H and Perez-Tilve, Diego
Diabetes, ISSN 0012-1797, 11/2012, Volume 61, Issue 11, pp. 2753 - 2762
We studied interscapular brown adipose tissue (iBAT) activity in wild-type (WT) and glucagon-like peptide 1 receptor (GLP-1R)-deficient mice after the... 
BODY-WEIGHT | ENERGY-EXPENDITURE | GLUCOSE-INTOLERANCE | FOOD-INTAKE | ENDOCRINOLOGY & METABOLISM | BRAIN-STEM | MICE | HEART-RATE | RAT-BRAIN | COLD | OXYNTOMODULIN | Up-Regulation | Central Nervous System - metabolism | Ion Channels - genetics | Male | Mitochondrial Proteins - genetics | Scapula | Sympathetic Nervous System - metabolism | Adipose Tissue, Brown - innervation | Glucagon-Like Peptide 1 - agonists | Mitochondrial Proteins - metabolism | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | Trans-Activators - genetics | Neurons - metabolism | Oxyntomodulin - metabolism | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Mice, Inbred C57BL | Insulin Resistance | Receptors, Glucagon - metabolism | Nerve Tissue Proteins - genetics | Mice, Knockout | Nerve Tissue Proteins - metabolism | Animals | Thermogenesis | Glucagon-Like Peptide-1 Receptor | Ion Channels - metabolism | Glucagon - metabolism | Trans-Activators - metabolism | Adipose Tissue, Brown - metabolism | Mice | Transcription Factors | Uncoupling Protein 1 | Physiological aspects | Brown adipose tissue | Research | Analysis | Metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans
by Finan, Brian and Ma, Tao and Ottaway, Nickki and Müller, Timo D and Habegger, Kirk M and Heppner, Kristy M and Kirchner, Henriette and Holland, Jenna and Hembree, Jazzminn and Raver, Christine and Lockie, Sarah H and Smiley, David L and Gelfanov, Vasily and Yang, Bin and Hofmann, Susanna and Bruemmer, Dennis and Drucker, Daniel J and Pfluger, Paul T and Perez-Tilve, Diego and Gidda, Jaswant and Vignati, Louis and Zhang, Lianshan and Hauptman, Jonathan B and Lau, Michele and Brecheisen, Mathieu and Uhles, Sabine and Riboulet, William and Hainaut, Emmanuelle and Sebokova, Elena and Conde-Knape, Karin and Konkar, Anish and DiMarchi, Richard D and Tschöp, Matthias H
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra151 - 209ra151
We report the discovery and translational therapeutic efficacy of a peptide with potent, balanced co-agonism at both of the receptors for the incretin hormones... 
MEDICINE, RESEARCH & EXPERIMENTAL | BODY-WEIGHT | GLYCEMIC CONTROL | HIGH-FAT DIET | GLUCOSE-INTOLERANCE | ENTEROINSULAR AXIS | PANCREATIC BETA-CELLS | DEPENDENT INSULINOTROPIC POLYPEPTIDE | GASTRIC-INHIBITORY POLYPEPTIDE | LIPOPROTEIN-LIPASE | PEPTIDE YY3-36 | CELL BIOLOGY | Acylation - drug effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Male | Rodentia - metabolism | Weight Loss - drug effects | Hyperglycemia - drug therapy | Young Adult | Incretins - pharmacology | Adult | Female | Gastric Inhibitory Polypeptide - pharmacology | Receptors, Glucagon - agonists | Glucose Tolerance Test | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Rats | Receptors, Glucagon - metabolism | Treatment Outcome | Haplorhini - metabolism | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Adolescent | Aged | Mice | Venoms - pharmacology | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Receptors, Gastrointestinal Hormone | Incretins - administration & dosage | Liraglutide | Medicin och hälsovetenskap | Medicinsk bioteknologi (inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinsk bioteknologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain
by Heppner, Kristy M and Kirigiti, Melissa and Secher, Anna and Paulsen, Sarah Juel and Buckingham, Rikley and Pyke, Charles and Knudsen, Lotte B and Vrang, Niels and Grove, Kevin L
Endocrinology, ISSN 0013-7227, 01/2015, Volume 156, Issue 1, pp. 255 - 267
Glucagon-like peptide-1 (GLP-1) is released from endocrine L-cells lining the gut in response to food ingestion. However, GLP-1 is also produced in the nucleus... 
BODY-WEIGHT | FOOD-INTAKE | ALZHEIMERS-DISEASE | ENDOCRINOLOGY & METABOLISM | GLP-1 RECEPTORS | RAT-BRAIN | HEART-RATE | TYPE-2 DIABETES-MELLITUS | NONDIABETIC ADULTS | BLOOD-PRESSURE | SHORT-TERM | Receptors, Glucagon - genetics | Antibody Specificity | Glucagon-Like Peptide 1 | RNA, Messenger - genetics | Antibodies | Gene Expression Regulation - physiology | Receptors, Glucagon - metabolism | Male | Macaca mulatta | RNA, Messenger - metabolism | Brain - metabolism | Tissue Distribution | Animals | In Situ Hybridization | Glucagon-Like Peptide-1 Receptor | Protein Binding | Neuroendocrinology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice
by Heppner, Kristy M and Marks, Sarah and Holland, Jenna and Ottaway, Nickki and Smiley, David and Dimarchi, Richard and Perez-Tilve, Diego
Diabetologia, ISSN 0012-186X, 9/2015, Volume 58, Issue 9, pp. 2124 - 2132
We assessed the contribution of glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) signalling to thermogenesis induced by high-fat diet (HFD) consumption.... 
GLP-1 | Medicine & Public Health | Human Physiology | High-fat diet | Metabolic Diseases | Internal Medicine | Brown adipose tissue | Liraglutide | Diet-induced thermogenesis | EXPENDITURE | OBESITY | MODELS | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | FAT | ABLATION | WEIGHT | GLUCAGON | Body Composition | Eating | Temperature | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Mice, Inbred C57BL | Oxygen Consumption | Liraglutide - chemistry | Male | Calorimetry, Indirect | Mice, Knockout | Glucagon-Like Peptide-1 Receptor - metabolism | Phenotype | Animals | Thermogenesis | Diet | Norepinephrine - chemistry | Diet, High-Fat | Mice, Obese | Adipose Tissue, Brown - metabolism | Mice | Energy Metabolism - physiology | Adipose tissues | Physiological aspects | Peptides | Analysis | Body weight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Ablation of Ghrelin O-Acyltransferase Does Not Improve Glucose Intolerance or Body Adiposity in Mice on a Leptin-Deficient ob/ob Background
by Kirchner, Henriette and Heppner, Kristy M and Holland, Jenna and Kabra, Dhiraj and Tschöp, Matthias H and Pfluger, Paul T
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61822
Type 2 Diabetes is a global health burden and based on current estimates will become an even larger problem in the future. Developing new strategies to prevent... 
UNACYLATED GHRELIN | FOOD-INTAKE | MULTIDISCIPLINARY SCIENCES | BETA-CELLS | GROWTH | ENDOCRINE | HUMANS | HORMONE SECRETAGOGUE RECEPTOR | DES-ACYL GHRELIN | STIMULATES INSULIN-SECRETION | PEPTIDE | Body Weight | Acyltransferases - deficiency | Homeostasis | Male | Gene Knockout Techniques | Acyltransferases - genetics | Obesity - blood | Glucose Intolerance - blood | Mice, Knockout | Ghrelin - metabolism | Ghrelin - blood | Phenotype | Animals | Adiposity | Glucose - metabolism | Glucose Intolerance - enzymology | Female | Mice, Obese | Mice | Obesity - enzymology | Protein Processing, Post-Translational | Leptin - deficiency | Acylation | Type 2 diabetes | Glucose metabolism | Enzymes | Leptin | Analysis | Glucose | Dextrose | Animal models | Adipose tissue | Gene deletion | Kinases | Clonal deletion | Ghrelin | Rodents | Deletion | Pancreas | Public health | Food | Stomach | Obesity | Diabetes mellitus | Metabolism | Hypoglycemia | Acyltransferase | Insulin | Ablation | Glucose tolerance | Intolerance | Weight control | Diet | Isoforms | Diabetes | Metabolic disorders | Endocrinology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors
by Heppner, Kristy M and Piechowski, Carolin L and Müller, Anne and Ottaway, Nickki and Sisley, Stephanie and Smiley, David L and Habegger, Kirk M and Pfluger, Paul T and DiMarchi, Richard and Biebermann, Heike and Tschöp, Matthias H and Sandoval, Darleen A and Perez-Tilve, Diego
Diabetes, ISSN 0012-1797, 01/2014, Volume 63, Issue 1, pp. 122 - 131
Growth hormone secretagogue receptors (GHSRs) in the central nervous system (CNS) mediate hyperphagia and adiposity induced by acyl ghrelin (AG). Evidence... 
HEALTHY HUMANS | RODENTS | MECHANISM | UNACYLATED GHRELIN | ENERGY HOMEOSTASIS | FOOD-INTAKE | INSULIN-SECRETION | ENDOCRINOLOGY & METABOLISM | HORMONE SECRETAGOGUE RECEPTOR | ARCUATE NUCLEUS | PEPTIDE | Adiposity - drug effects | Animals | Central Nervous System - metabolism | Ghrelin - administration & dosage | Humans | HEK293 Cells | Glucose - metabolism | Receptors, Ghrelin - metabolism | Ghrelin - pharmacology | Adiposity - physiology | Mice | Infusions, Intraventricular | Glucose metabolism | Cell receptors | Genetic aspects | Properties | Ghrelin | Identification and classification | Metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights